Jane Street’s Greenwich LifeSciences GLSI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$650K Buy
+27,694
New +$674K ﹤0.01% 7444
2026
Q1
Sell
-9,677
Closed -$203K 12087
2025
Q4
$203K Buy
+9,677
New +$102K ﹤0.01% 9690
2024
Q2
Sell
-20,642
Closed -$412K 9674
2024
Q1
$412K Buy
20,642
+6,637
+47% +$81.9K ﹤0.01% 7039
2023
Q4
$147K Buy
+14,005
New +$140K ﹤0.01% 8404
2023
Q2
Sell
-18,510
Closed -$255K 9003
2023
Q1
$255K Buy
+18,510
New +$294K ﹤0.01% 7451
2022
Q1
Sell
-8,570
Closed -$209K 10554
2021
Q4
$209K Buy
8,570
+1,679
+24% +$56.2K ﹤0.01% 8749
2021
Q3
$269K Buy
6,891
+1,388
+25% +$58K ﹤0.01% 8390
2021
Q2
$247K Buy
+5,503
New +$208K ﹤0.01% 8485

Other funds holding GLSI

Jane Street's GLSI Position: Q2 2026 in Review

Jane Street opened a new position in Greenwich LifeSciences (GLSI) in Q2 2026: 27,694 shares worth $650K. The stake represents ﹤0.01% of the portfolio and ranks #7444 among its holdings. This is a return to the name: Jane Street previously reported a position in GLSI as recently as Q4 2025.

Jane Street first reported a position in GLSI in Q2 2021 and has held it in 8 quarters since. 58 funds tracked by Wall St. Rank hold GLSI as of Q2 2026.

  • Jane Street held 27,694 shares of Greenwich LifeSciences worth $650K as of Q2 2026.
  • Greenwich LifeSciences was a new Jane Street position in Q2 2026.
  • Greenwich LifeSciences made up ﹤0.01% of Jane Street's portfolio in Q2 2026, its #7444 holding.
  • Jane Street first reported a position in Greenwich LifeSciences in Q2 2021 and has held it in 8 quarters since.
  • 58 funds tracked by Wall St. Rank held Greenwich LifeSciences as of Q2 2026.

Based on Jane Street's 13F filing for Q2 2026, filed 14 Aug 2026.